| Back |
|
| Knock down the infection with a sharp punch |
| Product Name: |
| Tablets |
| Roxithromycin 150 mg |
| A winning edge over multi infections |
| Lower Respiratory Tract infections - Better tolerated with the advantage of a once a daily dose compared to clarithromycin in the treatment of lower respiratory tract infections |
| Sinusitis - Clinical efficacy was 93% with roxithromycin as compared to 88% with co-amoxiclav |
| Community Acquired Pneumonia - Roxithromycin with long half life & good tissue penetration gives 100% clinical cure in 30 mild to moderate cases of community acquired pneumonia. |
| Helicobacter pylori infections - Well tolerated & absorbed, Achieves high tissue & intracellular concentrations in the treatment of Helicobacter pylori infections |
|
| Also available: REFOXIL-DT 50 Tablets (Roxithromycin 50 mg),REFOXIL-M Tablets (Roxithromycin 150 mg, Ambroxol 30 mg)
|
|
|
Medical Jr.
| 1. Journal of antimicrobial Chemotherapy 1998 ; 41, Suppl B, 69-73
|
| 2. Journal of antimicrobial Chemotherapy 1998 ; 41, Suppl B, 81-84
|
| 3. Journal of antimicrobial Chemotherapy 1998 ; 41, Suppl B, 75-80
|
| 4. Journal of antimicrobial Chemotherapy 1998 ; 41, Suppl B, 29-35
|
|
| |
|
 |